Recombinant protein as a Pan Fc Receptor Interacting Molecule
Engineering of an oligomeric Fc protein which is capable of interacting with all human Fcγ receptors with enhanced binding activity. We call the molecule PRIM for Pan Receptor Interacting Molecule. PRIM is highly efficacious in autoimmune animal models and is a developmental candidate for replacing the traditional plasma-derived human IVIG.
Recombinant protein as a Pan Fc Receptor Interacting molecule
Cancer treatment via symbiosis with tumor tissues through slowing down the progression of cancer-triggered cachexia.
Massive antibody mining, an unique platform for accelerating R&D timelines of therapeutic antibodies.
Niche platform technology for life cycle maintenance of approved antibody drugs.
Next generation CAR-T modules.